IGF1R and colorectal carcinoma: Recently, it was reported that lower expression of miR-143 in CRC was correlated with clinical stages and lymph node metastasis and was responsible for drug resistance by targeting the insulin-like growth factor-I receptor (IGF-IR) [81].